We show that the appearance of both NF-κB and IFN signatures are well-correlated with VHL mutational status, and identify a key subset of NF-κB regulators and targets whose elevated expression correlates with higher relative-risk, poorer prognosis, and reduced overall survival in ccRCC. Here, NFKB1 is linked to nonpapillary renal cell carcinoma.